Hypergastrinemia is a prominent feature of a segment of gastroenetropancreatic neuroendocrine tumours, the gastrinomas, mostly occurring in the gastrinoma triangle.
INTRODUCTION
Neuroendocrine tumours (NET) are tumours arising from the neuroendocrine cells, which are the peptide and amine producing cells dispersed throughout the body. Gastrinomas are a type of NET which secretes the hormone gastrin leading to hypergastrinemia. The most common site of these gastrinomas (more than 80%) is the gastrinoma triangle, bounded by the cystic and common bile duct superiorly, the second and third portions of the duodenum inferiorly and the neck and body of the pancreas medially. Clinically, hypergastrinemia causes increase in the gastric acid secretion and the symptoms of gastrinoma are associated with peptic ulcer disease, diarrhoea and reflux esophagitis. Dyspepsia, haemorrhage and abdominal pain are related to hyperacidity (1) . Hypergastrinemia is a rare occurrence in cases of thoracic NETs. There are very few reports supporting the same in the literature.
CASE REPORT
A 44 years old male, initially presented with history of hyperacidity, recurrent diarrhoea and vomiting since 3 years. He was continuously being treated with proton pump inhibitors which relieved him of the symptoms for a short duration and recurrence following discontinuation of medications. Multidetector CT (MDCT) of abdomen done previously showed diffuse wall thickening with enhancement of gastric rugae in the fundus and body regions of the stomach. Incidental horse shoe kidney was also detected. Upper and lower GI endoscopy and the biopsy from the stomach was repeatedly negative for malignancy. The only positive finding for OGDscopy was esophagitis, thick folds and duodenitis. Fasting serum gastrin level was raised (674 ng/ml). The local reference range for serum gastrin level is 13-115 pg/ml.
The patient was referred for SSTR targeted imaging for suspected gastrinoma. The 68 Ga-DOTATATE scan showed a solitary focus of uptake and SSTR expression in the paraaortic mass in the left lung (Fig 1 left panel and 2) . A review of the previous done CT was undertaken: the lower chest sections of the CT (Fig 1 right panel) showed a para-aortic mass near the thoracic descending aorta in the left lung, which was incidentally missed. The para-aortic mass was excised by video assisted thoracoscopic surgery (VATS) and the histopathology was suggestive of neuroendocrine tumour (Mib1 labeling index of 2 %) with immunohistochemistry positive for synaptophysin, chromogranin and CD 56. At this follow-up point (one and half month post surgery), the patient is being observed with next follow-up at 3 months.
DISCUSSION
Hypergastrinemia is a condition with raised fasting serum gastrin levels. The most common cause of hypergastrinemia is gastrinoma, a type of neuroendocrine tumour.
Gastrinomas causing the Zollinger-Ellison syndrome are almost exclusively located in the abdomen, primarily in the duodenum or pancreas, and rarely in the stomach, mesentery, spleen, liver and ovaries. In 10-50% of cases, gastrinomas cannot be located in the abdomen even after careful abdominal exploration. Though most missed gastrinomas are present in the duodenum or pancreas, the present case shows that extra-abdominal cause is possible.
Hypergastrinemia is rarely encountered in a thoracic NET. It has been reported in rare cases of cardiac gastrinoma (2, 3) , cases of bronchoalveolar carcinoids associated with MEN 1 Syndrome (4), non small cell carcinoma of lung (5) MEN1 syndrome is an autosomal dominant syndrome associated with tumours of pituitary, pancreas and parathyroid. Bronchopulmonary carcinoids are very rare. In a study carried out for incidence of bronchopulmonary carcinoids in MEN 1 syndrome patients, the incidence was found to be 5% (4) and hypergastrinemia was common in patients with the pulmonary nodules as compared to the other patients.
Conclusion:
Thus, the present case illustrates the importance of 68 Ga-DOTATATE PET-CT in detecting a lesion that was missed on the ceCT. Additionally important is the fact that even if it had not been missed, it would be impossible to characterize this mass a neuroendocrine tumor based on CT alone and underscores the importance of somatostain receptor based PET imaging. 
